Previous close | 1,766.00 |
Open | 1,757.80 |
Bid | 1,789.80 x 0 |
Ask | 1,789.80 x 0 |
Day's range | 1,751.40 - 1,793.00 |
52-week range | 1,215.83 - 2,726.53 |
Volume | |
Avg. volume | 11,947,072 |
Market cap | 91.157B |
Beta (5Y monthly) | 0.29 |
PE ratio (TTM) | 1,775.25 |
EPS (TTM) | 1.01 |
Earnings date | 27 Jul 2022 |
Forward dividend & yield | 0.75 (4.25%) |
Ex-dividend date | 19 May 2022 |
1y target est | 1,805.24 |
PHILADELPHIA, June 29, 2022--GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community
GlaxoSmithKline (GSK) closed the most recent trading day at $43.35, moving -0.8% from the previous trading session.
Gilead (GILD) announces the resubmission of the NDA for lenacapavir, an investigational, long-acting HIV-1 capsid inhibitor, for the treatment of HIV-1 infection in the United States.